Literature DB >> 19878312

Death-associated protein kinase (DAPK) and signal transduction: blebbing in programmed cell death.

Miia Bovellan1, Marco Fritzsche, Craig Stevens, Guillaume Charras.   

Abstract

Death-associated protein kinase (DAPK) regulates many distinct signalling events, including apoptosis, autophagy and membrane blebbing. The role of DAPK in the blebbing process is only beginning to be understood and, in this review, we will first summarize what is known about the cytoskeletal proteins and signalling cascades that participate in bleb growth and retraction and then highlight how DAPK integrates with these processes. Membrane blebs are quasispherical cellular protrusions that have a lifetime of approximately 2 min. During expansion, blebs are initially devoid of actin, although actomyosin contractions provide the motive force for growth. Once growth slows, an actin cortex reforms and actin-bundling and contractile proteins are recruited. Finally, myosin contraction powers bleb retraction into the cell body. Blebbing occurs in a variety of cell types, from cancerous cells to embryonic cells, and can be seen in cellular phenomena as diverse as cell spreading, movement, cytokinesis and cell death. Although the machinery that executes this is still undefined in detail, the conservation of blebbing phenomenon suggests a fundamental role in metazoans and DAPK offers a door to further dissect this fascinating process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878312     DOI: 10.1111/j.1742-4658.2009.07412.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  26 in total

1.  Death-associated protein kinase 1 phosphorylates NDRG2 and induces neuronal cell death.

Authors:  Mi-Hyeon You; Byeong Mo Kim; Chun-Hau Chen; Michael J Begley; Lewis C Cantley; Tae Ho Lee
Journal:  Cell Death Differ       Date:  2016-11-04       Impact factor: 15.828

2.  Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function.

Authors:  Tae Ho Lee; Chun-Hau Chen; Futoshi Suizu; Pengyu Huang; Cordelia Schiene-Fischer; Sebastian Daum; Yan Jessie Zhang; Alison Goate; Ruey-Hwa Chen; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Mol Cell       Date:  2011-04-14       Impact factor: 17.970

3.  Identification of Novel Death-Associated Protein Kinase 2 Interaction Partners by Proteomic Screening Coupled with Bimolecular Fluorescence Complementation.

Authors:  Barbara Geering; Zina Zokouri; Samuel Hürlemann; Bertran Gerrits; David Ausländer; Adrian Britschgi; Mario P Tschan; Hans-Uwe Simon; Martin Fussenegger
Journal:  Mol Cell Biol       Date:  2015-10-19       Impact factor: 4.272

4.  Autophagy modulates articular cartilage vesicle formation in primary articular chondrocytes.

Authors:  Ann K Rosenthal; Claudia M Gohr; Elizabeth Mitton-Fitzgerald; Rupinder Grewal; James Ninomiya; Carolyn B Coyne; William T Jackson
Journal:  J Biol Chem       Date:  2015-04-13       Impact factor: 5.157

5.  Microparticles as autoantigens: making immune complexes big.

Authors:  David S Pisetsky
Journal:  Arthritis Rheum       Date:  2012-01-11

6.  Protein Kinase-Mediated Decision Between the Life and Death.

Authors:  Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Survival by self-destruction: a role for autophagy in the placenta?

Authors:  I Bildirici; M S Longtine; B Chen; D M Nelson
Journal:  Placenta       Date:  2012-05-30       Impact factor: 3.481

Review 8.  Myosin light chain kinases and phosphatase in mitosis and cytokinesis.

Authors:  Fumio Matsumura; Yoshihiko Yamakita; Shigeko Yamashiro
Journal:  Arch Biochem Biophys       Date:  2011-03-21       Impact factor: 4.013

Review 9.  Extracellular vesicles shed by glioma cells: pathogenic role and clinical value.

Authors:  Dimitry A Chistiakov; Vladimir P Chekhonin
Journal:  Tumour Biol       Date:  2014-06-27

Review 10.  The therapeutic target Hsp90 and cancer hallmarks.

Authors:  Yoshihiko Miyata; Hitoshi Nakamoto; Len Neckers
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.